Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

Clinical trial NCT04068649 · RECRUITING

Trial details

NCT number: NCT04068649
Sponsor: Roswell Park Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm

Start date: 2019-11-18
Primary completion: 2027-11-18
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.